nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Zalcitabine—Gemcitabine—urinary bladder cancer	0.425	1	CrCrCtD
Didanosine—SLC29A2—Gemcitabine—urinary bladder cancer	0.218	0.474	CbGbCtD
Didanosine—SLC29A1—Gemcitabine—urinary bladder cancer	0.125	0.272	CbGbCtD
Didanosine—SLC29A1—Fluorouracil—urinary bladder cancer	0.107	0.233	CbGbCtD
Didanosine—SLC22A6—Methotrexate—urinary bladder cancer	0.00945	0.0205	CbGbCtD
Didanosine—SLC29A2—prostate gland—urinary bladder cancer	0.00301	0.171	CbGeAlD
Didanosine—PNP—renal system—urinary bladder cancer	0.00274	0.156	CbGeAlD
Didanosine—PNP—Purine catabolism—GPX1—urinary bladder cancer	0.00268	0.164	CbGpPWpGaD
Didanosine—PNP—female reproductive system—urinary bladder cancer	0.00219	0.125	CbGeAlD
Didanosine—SLC29A2—female reproductive system—urinary bladder cancer	0.00165	0.0936	CbGeAlD
Didanosine—SLC29A1—prostate gland—urinary bladder cancer	0.00149	0.085	CbGeAlD
Didanosine—PNP—Daunorubicin—Valrubicin—urinary bladder cancer	0.00149	0.599	CbGdCrCtD
Didanosine—SLC29A2—vagina—urinary bladder cancer	0.00149	0.0846	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00126	0.0773	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TYMP—urinary bladder cancer	0.00121	0.074	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—GPX1—urinary bladder cancer	0.00103	0.063	CbGpPWpGaD
Didanosine—SLC29A1—renal system—urinary bladder cancer	0.00102	0.0579	CbGeAlD
Didanosine—SLC29A1—urethra—urinary bladder cancer	0.001	0.0569	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000987	0.0604	CbGpPWpGaD
Didanosine—SLC29A2—lymph node—urinary bladder cancer	0.000963	0.0547	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000945	0.0577	CbGpPWpGaD
Didanosine—SLC29A1—female reproductive system—urinary bladder cancer	0.000816	0.0464	CbGeAlD
Didanosine—SLC29A1—vagina—urinary bladder cancer	0.000738	0.042	CbGeAlD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000578	0.0353	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000572	0.0349	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000547	0.0334	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000531	0.0325	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Epirubicin—urinary bladder cancer	0.000519	0.208	CbGdCrCtD
Didanosine—PNP—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000518	0.0316	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000499	0.0305	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—urinary bladder cancer	0.00048	0.193	CbGdCrCtD
Didanosine—SLC29A1—lymph node—urinary bladder cancer	0.000477	0.0271	CbGeAlD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.0004	0.0245	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000352	0.0215	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000294	0.0179	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000212	0.013	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000203	0.0124	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTZ1—urinary bladder cancer	0.000191	0.0117	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.00019	0.0116	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTO2—urinary bladder cancer	0.000181	0.0111	CbGpPWpGaD
Didanosine—PNP—Metabolism—NAT1—urinary bladder cancer	0.000181	0.0111	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000173	0.0106	CbGpPWpGaD
Didanosine—Myalgia—Thiotepa—urinary bladder cancer	0.00017	0.00217	CcSEcCtD
Didanosine—Dry eye—Epirubicin—urinary bladder cancer	0.000169	0.00217	CcSEcCtD
Didanosine—Alopecia—Fluorouracil—urinary bladder cancer	0.000167	0.00214	CcSEcCtD
Didanosine—PNP—Metabolism—UGT2B7—urinary bladder cancer	0.000166	0.0101	CbGpPWpGaD
Didanosine—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000164	0.00209	CcSEcCtD
Didanosine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.000164	0.00209	CcSEcCtD
Didanosine—Infection—Thiotepa—urinary bladder cancer	0.000162	0.00206	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00016	0.00978	CbGpPWpGaD
Didanosine—Neuropathy—Doxorubicin—urinary bladder cancer	0.000159	0.00204	CcSEcCtD
Didanosine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000159	0.00204	CcSEcCtD
Didanosine—Alopecia—Cisplatin—urinary bladder cancer	0.000159	0.00203	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—urinary bladder cancer	0.000158	0.00202	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—urinary bladder cancer	0.000157	0.002	CcSEcCtD
Didanosine—Anorexia—Thiotepa—urinary bladder cancer	0.000155	0.00198	CcSEcCtD
Didanosine—Anaemia—Gemcitabine—urinary bladder cancer	0.000155	0.00198	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—urinary bladder cancer	0.000154	0.00197	CcSEcCtD
Didanosine—Flatulence—Cisplatin—urinary bladder cancer	0.000154	0.00197	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.000153	0.00196	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000153	0.00196	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.000152	0.00195	CcSEcCtD
Didanosine—Anaemia—Fluorouracil—urinary bladder cancer	0.000152	0.00195	CcSEcCtD
Didanosine—Malaise—Gemcitabine—urinary bladder cancer	0.000151	0.00193	CcSEcCtD
Didanosine—Leukopenia—Gemcitabine—urinary bladder cancer	0.00015	0.00192	CcSEcCtD
Didanosine—PNP—Metabolism—CYP4B1—urinary bladder cancer	0.000149	0.00913	CbGpPWpGaD
Didanosine—Hepatic failure—Epirubicin—urinary bladder cancer	0.000148	0.00189	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000148	0.00189	CcSEcCtD
Didanosine—Chills—Etoposide—urinary bladder cancer	0.000147	0.00189	CcSEcCtD
Didanosine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000147	0.00189	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000147	0.00899	CbGpPWpGaD
Didanosine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000147	0.00188	CcSEcCtD
Didanosine—Paraesthesia—Thiotepa—urinary bladder cancer	0.000146	0.00187	CcSEcCtD
Didanosine—Alopecia—Etoposide—urinary bladder cancer	0.000145	0.00186	CcSEcCtD
Didanosine—Anaemia—Cisplatin—urinary bladder cancer	0.000144	0.00185	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—urinary bladder cancer	0.000144	0.00184	CcSEcCtD
Didanosine—Dyspepsia—Thiotepa—urinary bladder cancer	0.000143	0.00183	CcSEcCtD
Didanosine—Myalgia—Gemcitabine—urinary bladder cancer	0.000143	0.00182	CcSEcCtD
Didanosine—Arthralgia—Gemcitabine—urinary bladder cancer	0.000143	0.00182	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.000142	0.00181	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000142	0.00181	CcSEcCtD
Didanosine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000141	0.00181	CcSEcCtD
Didanosine—PNP—Metabolism—SLC19A1—urinary bladder cancer	0.000141	0.00862	CbGpPWpGaD
Didanosine—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000141	0.0018	CcSEcCtD
Didanosine—Discomfort—Gemcitabine—urinary bladder cancer	0.000141	0.0018	CcSEcCtD
Didanosine—Malaise—Cisplatin—urinary bladder cancer	0.000141	0.0018	CcSEcCtD
Didanosine—Myalgia—Fluorouracil—urinary bladder cancer	0.00014	0.00179	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—urinary bladder cancer	0.00014	0.00179	CcSEcCtD
Didanosine—Leukopenia—Cisplatin—urinary bladder cancer	0.00014	0.00179	CcSEcCtD
Didanosine—Pain—Thiotepa—urinary bladder cancer	0.000139	0.00178	CcSEcCtD
Didanosine—Discomfort—Fluorouracil—urinary bladder cancer	0.000139	0.00177	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000138	0.00176	CcSEcCtD
Didanosine—PNP—Metabolism—PRSS3—urinary bladder cancer	0.000137	0.0084	CbGpPWpGaD
Didanosine—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000137	0.00175	CcSEcCtD
Didanosine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000137	0.00175	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000136	0.00174	CcSEcCtD
Didanosine—Infection—Gemcitabine—urinary bladder cancer	0.000136	0.00174	CcSEcCtD
Didanosine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000134	0.00172	CcSEcCtD
Didanosine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000134	0.00171	CcSEcCtD
Didanosine—Infection—Fluorouracil—urinary bladder cancer	0.000134	0.00171	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000133	0.00171	CcSEcCtD
Didanosine—Myalgia—Cisplatin—urinary bladder cancer	0.000133	0.0017	CcSEcCtD
Didanosine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000133	0.0017	CcSEcCtD
Didanosine—Anaemia—Etoposide—urinary bladder cancer	0.000132	0.00169	CcSEcCtD
Didanosine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000132	0.00168	CcSEcCtD
Didanosine—Discomfort—Cisplatin—urinary bladder cancer	0.000131	0.00168	CcSEcCtD
Didanosine—Anorexia—Gemcitabine—urinary bladder cancer	0.00013	0.00167	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—urinary bladder cancer	0.000129	0.00166	CcSEcCtD
Didanosine—Malaise—Etoposide—urinary bladder cancer	0.000129	0.00165	CcSEcCtD
Didanosine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000129	0.00164	CcSEcCtD
Didanosine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000129	0.00164	CcSEcCtD
Didanosine—Anorexia—Fluorouracil—urinary bladder cancer	0.000128	0.00164	CcSEcCtD
Didanosine—Leukopenia—Etoposide—urinary bladder cancer	0.000128	0.00164	CcSEcCtD
Didanosine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000127	0.00163	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000127	0.00163	CcSEcCtD
Didanosine—Infection—Cisplatin—urinary bladder cancer	0.000127	0.00162	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000126	0.00161	CcSEcCtD
Didanosine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000125	0.0016	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000125	0.00159	CcSEcCtD
Didanosine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000123	0.00157	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000123	0.00157	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000122	0.00156	CcSEcCtD
Didanosine—Anorexia—Cisplatin—urinary bladder cancer	0.000121	0.00155	CcSEcCtD
Didanosine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000121	0.00154	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—urinary bladder cancer	0.000121	0.00154	CcSEcCtD
Didanosine—Discomfort—Etoposide—urinary bladder cancer	0.00012	0.00154	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00012	0.00733	CbGpPWpGaD
Didanosine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00012	0.00153	CcSEcCtD
Didanosine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000119	0.00152	CcSEcCtD
Didanosine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000118	0.00151	CcSEcCtD
Didanosine—Pain—Gemcitabine—urinary bladder cancer	0.000117	0.0015	CcSEcCtD
Didanosine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000117	0.00149	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000117	0.00714	CbGpPWpGaD
Didanosine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000117	0.00149	CcSEcCtD
Didanosine—Asthenia—Thiotepa—urinary bladder cancer	0.000117	0.00149	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000116	0.00148	CcSEcCtD
Didanosine—Infection—Etoposide—urinary bladder cancer	0.000116	0.00148	CcSEcCtD
Didanosine—Pruritus—Thiotepa—urinary bladder cancer	0.000115	0.00147	CcSEcCtD
Didanosine—Pain—Fluorouracil—urinary bladder cancer	0.000115	0.00147	CcSEcCtD
Didanosine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000114	0.00146	CcSEcCtD
Didanosine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000114	0.00146	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000113	0.00144	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000113	0.00144	CcSEcCtD
Didanosine—Anorexia—Etoposide—urinary bladder cancer	0.000111	0.00142	CcSEcCtD
Didanosine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000111	0.00142	CcSEcCtD
Didanosine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000111	0.00142	CcSEcCtD
Didanosine—PNP—Metabolism—TYMP—urinary bladder cancer	0.00011	0.00672	CbGpPWpGaD
Didanosine—Pain—Cisplatin—urinary bladder cancer	0.000109	0.00139	CcSEcCtD
Didanosine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000108	0.00138	CcSEcCtD
Didanosine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000106	0.00136	CcSEcCtD
Didanosine—Paraesthesia—Etoposide—urinary bladder cancer	0.000105	0.00134	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000104	0.00134	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000104	0.00133	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000104	0.00133	CcSEcCtD
Didanosine—Vomiting—Thiotepa—urinary bladder cancer	0.000103	0.00132	CcSEcCtD
Didanosine—Rash—Thiotepa—urinary bladder cancer	0.000102	0.00131	CcSEcCtD
Didanosine—Dermatitis—Thiotepa—urinary bladder cancer	0.000102	0.00131	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000102	0.00131	CcSEcCtD
Didanosine—Headache—Thiotepa—urinary bladder cancer	0.000102	0.0013	CcSEcCtD
Didanosine—Decreased appetite—Etoposide—urinary bladder cancer	0.000102	0.0013	CcSEcCtD
Didanosine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000101	0.00129	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000101	0.00129	CcSEcCtD
Didanosine—Pain—Etoposide—urinary bladder cancer	9.99e-05	0.00128	CcSEcCtD
Didanosine—PNP—Metabolism—NAT2—urinary bladder cancer	9.94e-05	0.00608	CbGpPWpGaD
Didanosine—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.91e-05	0.00127	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—urinary bladder cancer	9.85e-05	0.00126	CcSEcCtD
Didanosine—Asthenia—Gemcitabine—urinary bladder cancer	9.81e-05	0.00125	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	9.71e-05	0.00124	CcSEcCtD
Didanosine—Pruritus—Gemcitabine—urinary bladder cancer	9.68e-05	0.00124	CcSEcCtD
Didanosine—Nausea—Thiotepa—urinary bladder cancer	9.66e-05	0.00123	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	9.61e-05	0.00123	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—urinary bladder cancer	9.58e-05	0.00122	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—urinary bladder cancer	9.55e-05	0.00122	CcSEcCtD
Didanosine—Pruritus—Fluorouracil—urinary bladder cancer	9.51e-05	0.00122	CcSEcCtD
Didanosine—Hypersensitivity—Cisplatin—urinary bladder cancer	9.39e-05	0.0012	CcSEcCtD
Didanosine—Diarrhoea—Gemcitabine—urinary bladder cancer	9.36e-05	0.0012	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	9.31e-05	0.00119	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—urinary bladder cancer	9.23e-05	0.00118	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—urinary bladder cancer	9.23e-05	0.00118	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—urinary bladder cancer	9.21e-05	0.00118	CcSEcCtD
Didanosine—Diarrhoea—Fluorouracil—urinary bladder cancer	9.2e-05	0.00118	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—urinary bladder cancer	9.17e-05	0.00117	CcSEcCtD
Didanosine—Asthenia—Cisplatin—urinary bladder cancer	9.15e-05	0.00117	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	8.98e-05	0.00115	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—urinary bladder cancer	8.86e-05	0.00113	CcSEcCtD
Didanosine—Chills—Methotrexate—urinary bladder cancer	8.83e-05	0.00113	CcSEcCtD
Didanosine—Diarrhoea—Cisplatin—urinary bladder cancer	8.72e-05	0.00112	CcSEcCtD
Didanosine—Alopecia—Methotrexate—urinary bladder cancer	8.7e-05	0.00111	CcSEcCtD
Didanosine—Vomiting—Gemcitabine—urinary bladder cancer	8.69e-05	0.00111	CcSEcCtD
Didanosine—Rash—Gemcitabine—urinary bladder cancer	8.62e-05	0.0011	CcSEcCtD
Didanosine—Dermatitis—Gemcitabine—urinary bladder cancer	8.61e-05	0.0011	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—urinary bladder cancer	8.6e-05	0.0011	CcSEcCtD
Didanosine—PNP—Metabolism—RRM2—urinary bladder cancer	8.58e-05	0.00524	CbGpPWpGaD
Didanosine—Headache—Gemcitabine—urinary bladder cancer	8.57e-05	0.0011	CcSEcCtD
Didanosine—Vomiting—Fluorouracil—urinary bladder cancer	8.55e-05	0.00109	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—urinary bladder cancer	8.52e-05	0.00109	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	8.48e-05	0.00108	CcSEcCtD
Didanosine—Rash—Fluorouracil—urinary bladder cancer	8.48e-05	0.00108	CcSEcCtD
Didanosine—Dermatitis—Fluorouracil—urinary bladder cancer	8.47e-05	0.00108	CcSEcCtD
Didanosine—Headache—Fluorouracil—urinary bladder cancer	8.42e-05	0.00108	CcSEcCtD
Didanosine—Asthenia—Etoposide—urinary bladder cancer	8.38e-05	0.00107	CcSEcCtD
Didanosine—Chills—Epirubicin—urinary bladder cancer	8.27e-05	0.00106	CcSEcCtD
Didanosine—Pruritus—Etoposide—urinary bladder cancer	8.26e-05	0.00106	CcSEcCtD
Didanosine—Alopecia—Epirubicin—urinary bladder cancer	8.14e-05	0.00104	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.13e-05	0.00497	CbGpPWpGaD
Didanosine—Nausea—Gemcitabine—urinary bladder cancer	8.12e-05	0.00104	CcSEcCtD
Didanosine—Vomiting—Cisplatin—urinary bladder cancer	8.1e-05	0.00104	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.1e-05	0.00495	CbGpPWpGaD
Didanosine—Rash—Cisplatin—urinary bladder cancer	8.04e-05	0.00103	CcSEcCtD
Didanosine—Dermatitis—Cisplatin—urinary bladder cancer	8.03e-05	0.00103	CcSEcCtD
Didanosine—Diarrhoea—Etoposide—urinary bladder cancer	7.99e-05	0.00102	CcSEcCtD
Didanosine—Nausea—Fluorouracil—urinary bladder cancer	7.99e-05	0.00102	CcSEcCtD
Didanosine—PNP—Metabolism—ENO2—urinary bladder cancer	7.95e-05	0.00486	CbGpPWpGaD
Didanosine—PNP—Metabolism—HPGDS—urinary bladder cancer	7.95e-05	0.00486	CbGpPWpGaD
Didanosine—Anaemia—Methotrexate—urinary bladder cancer	7.92e-05	0.00101	CcSEcCtD
Didanosine—Flatulence—Epirubicin—urinary bladder cancer	7.9e-05	0.00101	CcSEcCtD
Didanosine—Malaise—Methotrexate—urinary bladder cancer	7.73e-05	0.000988	CcSEcCtD
Didanosine—PNP—Metabolism—GSTT1—urinary bladder cancer	7.71e-05	0.00471	CbGpPWpGaD
Didanosine—Leukopenia—Methotrexate—urinary bladder cancer	7.67e-05	0.000981	CcSEcCtD
Didanosine—Chills—Doxorubicin—urinary bladder cancer	7.65e-05	0.000978	CcSEcCtD
Didanosine—Nausea—Cisplatin—urinary bladder cancer	7.57e-05	0.000968	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—urinary bladder cancer	7.53e-05	0.000963	CcSEcCtD
Didanosine—Vomiting—Etoposide—urinary bladder cancer	7.42e-05	0.000949	CcSEcCtD
Didanosine—Anaemia—Epirubicin—urinary bladder cancer	7.41e-05	0.000948	CcSEcCtD
Didanosine—Rash—Etoposide—urinary bladder cancer	7.36e-05	0.000941	CcSEcCtD
Didanosine—Dermatitis—Etoposide—urinary bladder cancer	7.36e-05	0.00094	CcSEcCtD
Didanosine—Headache—Etoposide—urinary bladder cancer	7.32e-05	0.000935	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—urinary bladder cancer	7.31e-05	0.000935	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—urinary bladder cancer	7.3e-05	0.000933	CcSEcCtD
Didanosine—Myalgia—Methotrexate—urinary bladder cancer	7.3e-05	0.000933	CcSEcCtD
Didanosine—Malaise—Epirubicin—urinary bladder cancer	7.23e-05	0.000925	CcSEcCtD
Didanosine—Discomfort—Methotrexate—urinary bladder cancer	7.21e-05	0.000922	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—urinary bladder cancer	7.18e-05	0.000918	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.99e-05	0.000894	CcSEcCtD
Didanosine—Infection—Methotrexate—urinary bladder cancer	6.95e-05	0.000888	CcSEcCtD
Didanosine—Nausea—Etoposide—urinary bladder cancer	6.94e-05	0.000887	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—urinary bladder cancer	6.86e-05	0.000877	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.85e-05	0.000876	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—urinary bladder cancer	6.83e-05	0.000873	CcSEcCtD
Didanosine—Myalgia—Epirubicin—urinary bladder cancer	6.83e-05	0.000873	CcSEcCtD
Didanosine—Discomfort—Epirubicin—urinary bladder cancer	6.75e-05	0.000863	CcSEcCtD
Didanosine—Malaise—Doxorubicin—urinary bladder cancer	6.69e-05	0.000856	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—urinary bladder cancer	6.68e-05	0.000854	CcSEcCtD
Didanosine—Anorexia—Methotrexate—urinary bladder cancer	6.67e-05	0.000852	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—urinary bladder cancer	6.64e-05	0.000849	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.55e-05	0.000837	CcSEcCtD
Didanosine—Infection—Epirubicin—urinary bladder cancer	6.5e-05	0.000831	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.41e-05	0.000819	CcSEcCtD
Didanosine—PNP—Metabolism—NQO1—urinary bladder cancer	6.41e-05	0.00392	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	6.37e-05	0.000815	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—urinary bladder cancer	6.32e-05	0.000808	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—urinary bladder cancer	6.32e-05	0.000808	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—urinary bladder cancer	6.28e-05	0.000803	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—urinary bladder cancer	6.24e-05	0.000798	CcSEcCtD
Didanosine—Anorexia—Epirubicin—urinary bladder cancer	6.24e-05	0.000798	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—urinary bladder cancer	6.18e-05	0.00079	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—urinary bladder cancer	6.16e-05	0.000787	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—urinary bladder cancer	6.08e-05	0.000777	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.06e-05	0.000774	CcSEcCtD
Didanosine—Infection—Doxorubicin—urinary bladder cancer	6.02e-05	0.000769	CcSEcCtD
Didanosine—Pain—Methotrexate—urinary bladder cancer	5.98e-05	0.000765	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.96e-05	0.000762	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.93e-05	0.000758	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.88e-05	0.00359	CbGpPWpGaD
Didanosine—Paraesthesia—Epirubicin—urinary bladder cancer	5.88e-05	0.000751	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—urinary bladder cancer	5.77e-05	0.000738	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—urinary bladder cancer	5.76e-05	0.000737	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.72e-05	0.000731	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—urinary bladder cancer	5.69e-05	0.000728	CcSEcCtD
Didanosine—Pain—Epirubicin—urinary bladder cancer	5.6e-05	0.000716	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—urinary bladder cancer	5.53e-05	0.000707	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—urinary bladder cancer	5.53e-05	0.000707	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.52e-05	0.000706	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.47e-05	0.00334	CbGpPWpGaD
Didanosine—Paraesthesia—Doxorubicin—urinary bladder cancer	5.44e-05	0.000695	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	5.35e-05	0.000684	CcSEcCtD
Didanosine—PNP—Metabolism—GSTP1—urinary bladder cancer	5.34e-05	0.00327	CbGpPWpGaD
Didanosine—Dyspepsia—Doxorubicin—urinary bladder cancer	5.33e-05	0.000682	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—urinary bladder cancer	5.26e-05	0.000673	CcSEcCtD
Didanosine—Pain—Doxorubicin—urinary bladder cancer	5.18e-05	0.000662	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—urinary bladder cancer	5.17e-05	0.000662	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—urinary bladder cancer	5.17e-05	0.000662	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—urinary bladder cancer	5.15e-05	0.000659	CcSEcCtD
Didanosine—Asthenia—Methotrexate—urinary bladder cancer	5.02e-05	0.000642	CcSEcCtD
Didanosine—PNP—Metabolism—TYMS—urinary bladder cancer	4.97e-05	0.00304	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.95e-05	0.000633	CcSEcCtD
Didanosine—Pruritus—Methotrexate—urinary bladder cancer	4.95e-05	0.000633	CcSEcCtD
Didanosine—PNP—Metabolism—GSTM1—urinary bladder cancer	4.91e-05	0.003	CbGpPWpGaD
Didanosine—PNP—Metabolism—NCOR1—urinary bladder cancer	4.91e-05	0.003	CbGpPWpGaD
Didanosine—Hypersensitivity—Epirubicin—urinary bladder cancer	4.82e-05	0.000617	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.79e-05	0.00293	CbGpPWpGaD
Didanosine—Abdominal pain—Doxorubicin—urinary bladder cancer	4.79e-05	0.000612	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—urinary bladder cancer	4.79e-05	0.000612	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—urinary bladder cancer	4.79e-05	0.000612	CcSEcCtD
Didanosine—PNP—Metabolism—GPX1—urinary bladder cancer	4.7e-05	0.00287	CbGpPWpGaD
Didanosine—Asthenia—Epirubicin—urinary bladder cancer	4.7e-05	0.0006	CcSEcCtD
Didanosine—Pruritus—Epirubicin—urinary bladder cancer	4.63e-05	0.000592	CcSEcCtD
Didanosine—PNP—Metabolism—ERCC2—urinary bladder cancer	4.62e-05	0.00282	CbGpPWpGaD
Didanosine—Diarrhoea—Epirubicin—urinary bladder cancer	4.48e-05	0.000573	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.46e-05	0.000571	CcSEcCtD
Didanosine—Vomiting—Methotrexate—urinary bladder cancer	4.45e-05	0.000569	CcSEcCtD
Didanosine—Rash—Methotrexate—urinary bladder cancer	4.41e-05	0.000564	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—urinary bladder cancer	4.41e-05	0.000563	CcSEcCtD
Didanosine—Headache—Methotrexate—urinary bladder cancer	4.38e-05	0.00056	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—urinary bladder cancer	4.35e-05	0.000556	CcSEcCtD
Didanosine—PNP—Metabolism—MTHFR—urinary bladder cancer	4.34e-05	0.00265	CbGpPWpGaD
Didanosine—Pruritus—Doxorubicin—urinary bladder cancer	4.29e-05	0.000548	CcSEcCtD
Didanosine—Vomiting—Epirubicin—urinary bladder cancer	4.16e-05	0.000532	CcSEcCtD
Didanosine—Nausea—Methotrexate—urinary bladder cancer	4.15e-05	0.000531	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—urinary bladder cancer	4.14e-05	0.00053	CcSEcCtD
Didanosine—Rash—Epirubicin—urinary bladder cancer	4.13e-05	0.000528	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—urinary bladder cancer	4.12e-05	0.000527	CcSEcCtD
Didanosine—Headache—Epirubicin—urinary bladder cancer	4.1e-05	0.000524	CcSEcCtD
Didanosine—Nausea—Epirubicin—urinary bladder cancer	3.89e-05	0.000497	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—urinary bladder cancer	3.85e-05	0.000492	CcSEcCtD
Didanosine—Rash—Doxorubicin—urinary bladder cancer	3.82e-05	0.000488	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—urinary bladder cancer	3.82e-05	0.000488	CcSEcCtD
Didanosine—Headache—Doxorubicin—urinary bladder cancer	3.79e-05	0.000485	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.79e-05	0.00232	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—urinary bladder cancer	3.6e-05	0.00046	CcSEcCtD
Didanosine—PNP—Metabolism—PPARG—urinary bladder cancer	3.52e-05	0.00215	CbGpPWpGaD
Didanosine—PNP—Metabolism—CREBBP—urinary bladder cancer	3.38e-05	0.00207	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.24e-05	0.00198	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS2—urinary bladder cancer	2.77e-05	0.00169	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTEN—urinary bladder cancer	2.41e-05	0.00148	CbGpPWpGaD
Didanosine—PNP—Metabolism—EP300—urinary bladder cancer	2.3e-05	0.00141	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.52e-05	0.000926	CbGpPWpGaD
